eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
4/2019
vol. 11
 
Share:
Share:
abstract:
Case report

Application of tapentadol in elderly patients during systemic treatment – case report

Adriana Maria Stryczyńska-Mirocha
1
,
Martyna Mirocha
2

1.
Katowickie Centrum Onkologii
2.
Collegium Medicum Uniwersytetu Jagiellońskiego
Medycyna Paliatywna 2019; 11(4): 188–192
Online publish date: 2020/03/04
View full text Get citation
 
PlumX metrics:
The risk of developing cancer increases with age, and pain is one of the most common symptoms associated with cancer. Due to the frequent co-occurrence of other chronic diseases or ailments, the treatment of cancer pain in the elderly can be a challenge for specialists. The need for simultaneous use of many drugs and a high risk of their interaction means that in practice the choice of the appropriate analgesic cannot be accidental. Tapentadol is one of the drugs with a favourable pharmacokinetic profile. By combining in one molecule the μ opioid receptor agonist activity in the central nervous system and inhibiting noradrenaline reuptake in the descending anti-nociceptive system, it is highly effective in the treatment of moderate to severe cancer pain, also with a neuropathic component. Due to the low risk of drug interactions, tapentadol is a safe therapeutic option in patients with multiple diseases.
keywords:

tapentadol, pain treatment, elderly

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.